Your browser doesn't support javascript.
loading
Tert-butylhydroquinone and tert-butylcatechol positivity as warning lights of skin sensitization to tert-butylphenol derivatives in adhesives and diabetes devices.
Dendooven, Ella; Naessens, Tania; Foubert, Kenn; Hermans, Nina; Aerts, Olivier.
Affiliation
  • Dendooven E; Department of Dermatology, University Hospital Antwerp (UZA) and University of Antwerp (UA), Antwerp, Belgium.
  • Naessens T; Natural Products and Food Research and Analysis-Pharmaceutical Technology, Department of Pharmaceutical Sciences, University of Antwerp, Antwerp, Belgium.
  • Foubert K; Natural Products and Food Research and Analysis-Pharmaceutical Technology, Department of Pharmaceutical Sciences, University of Antwerp, Antwerp, Belgium.
  • Hermans N; Natural Products and Food Research and Analysis-Pharmaceutical Technology, Department of Pharmaceutical Sciences, University of Antwerp, Antwerp, Belgium.
  • Aerts O; Natural Products and Food Research and Analysis-Pharmaceutical Technology, Department of Pharmaceutical Sciences, University of Antwerp, Antwerp, Belgium.
Contact Dermatitis ; 2024 Aug 21.
Article de En | MEDLINE | ID: mdl-39168925
ABSTRACT

INTRODUCTION:

Tert-butylphenol (TBP) derivatives, antioxidants in adhesives and diabetes devices, may provoke allergic contact dermatitis (ACD).

OBJECTIVES:

The objective of this study is to report sensitization to TBP derivatives in medical devices and to highlight that tert-butylhydroquinone (BHQ) and tert-butylcatechol (TBC) are potential screeners in this regard.

METHODS:

Fifteen patients with ACD from adhesives and diabetes devices were patch tested to different TBPs BHQ 1% pet., TBC 0.25% pet., BHA 2% pet., BHT 2% pet., 4-tert-butylphenol (TBP) 1% pet. and 2,4-di-tert-butylphenol (di TBP) 1% pet. The culprit devices (medical adhesives, sanitary pads, diabetes devices) and TBP patch preparations were analysed using gas chromatography-mass spectrometry (GC-MS).

RESULTS:

BHQ (9/13), TBC (7/13), and to a lesser extent BHT (3/15), BHA (2/15) and TBP (2/13) gave positive reactions. Seven patients had developed ACD from adhesives and diabetes devices, respectively, and one patient from sanitary pads. GC-MS analyses of the medical devices and patch test materials confirmed the presence of the patch-test positive TBPs, or chemically related derivatives, or, interestingly, tert-butylbenzoquinones (BBQ) were found, that is, spontaneously formed, highly reactive TBP metabolites, likely (pseudo-) cross reacting with the patch tested TBPs.

CONCLUSION:

TBPs might be overlooked sensitizers in medical devices, and BHQ and TBC are potential screeners in this regard.
Mots clés

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Langue: En Journal: Contact Dermatitis Année: 2024 Type de document: Article Pays d'affiliation: Belgique

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Langue: En Journal: Contact Dermatitis Année: 2024 Type de document: Article Pays d'affiliation: Belgique